Useful resources |
Anti-IgE for chronic asthma in adults and children (Cochrane Review) ABSTRACT Background: Omalizumab is a recombinant humanised monoclonal antibody directed against immunoglobulin E (anti-IgE) to inhibit the immune system's response to allergen exposure. Omalizumab is directed against the binding site of IgE for its high affinity Fc recep . . . |
Full article: The full article is available on Wiley InterScience at http://www.thecochranelibrary.com |